These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21627985)

  • 21. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Taylor LS
    Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.
    Kanaze FI; Kokkalou E; Niopas I; Barmpalexis P; Georgarakis E; Bikiaris D
    Drug Dev Ind Pharm; 2010 Mar; 36(3):292-301. PubMed ID: 19663560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.
    Karavas E; Ktistis G; Xenakis A; Georgarakis E
    Drug Dev Ind Pharm; 2005 Jul; 31(6):473-89. PubMed ID: 16109621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe-based thermal and spectroscopic nanocharacterization methods.
    Qi S; Moffat JG; Yang Z
    Mol Pharm; 2013 Mar; 10(3):918-30. PubMed ID: 23320617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E; Georgarakis M; Docoslis A; Bikiaris D
    Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.
    Chen C; Xie X; Li Y; Zhou C; Song Y; Yan Z; Yang X
    Drug Dev Ind Pharm; 2014 Apr; 40(4):441-51. PubMed ID: 23614831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical stability studies of miscible amorphous solid dispersions.
    Ivanisevic I
    J Pharm Sci; 2010 Sep; 99(9):4005-12. PubMed ID: 20533553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K; Sawicki W; Kozyra A; Tajber L
    Eur J Pharm Biopharm; 2015 Oct; 96():237-46. PubMed ID: 26247119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoscale thermal analysis of pharmaceutical solid dispersions.
    Zhang J; Bunker M; Chen X; Parker AP; Patel N; Roberts CJ
    Int J Pharm; 2009 Oct; 380(1-2):170-3. PubMed ID: 19596429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preparation of felodipine/zein amorphous solid dispersions and in vitro evaluation using a dynamic gastrointestinal system.
    Zhang H; Liu X; Ma X
    Pharm Dev Technol; 2020 Dec; 25(10):1226-1237. PubMed ID: 32787680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
    Urbanetz NA
    Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion.
    Song Y; Wang L; Yang P; Wenslow RM; Tan B; Zhang H; Deng Z
    J Pharm Sci; 2013 Jun; 102(6):1915-1923. PubMed ID: 23580396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inkjet printing as a novel medicine formulation technique.
    Scoutaris N; Alexander MR; Gellert PR; Roberts CJ
    J Control Release; 2011 Dec; 156(2):179-85. PubMed ID: 21827800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.
    Karavas E; Georgarakis E; Bikiaris D
    Int J Pharm; 2006 Apr; 313(1-2):189-97. PubMed ID: 16483734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.